NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/25/2025
Back to search
Official data from USPTO
CLUNGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
03/25/2025
Trademark type
Combined
Nice classes
5
Filing date
06/21/2024
Registration date
03/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/25/2025
Last transaction
03/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/17/2018
First use in commerce
11/17/2018
Drawing code
3
Owner type
99
Owner location
Zhejiang, CN
Examiner
MCMORROW, RONALD G
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "CLUNGENE". The initial "C" consists of many horizontal lines.
Holders and representatives
Holders
Hangzhou Clongene Biotech Co., Ltd.
Representatives
Yue (Robert) Xu Apex Attorneys at Law, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic biomarkers for in vitro testing for medical use; Diagnostic kits comprising diagnostic agentspreparations and substances for medical purposes; Diagnostic kits comprising diagnostic agentspreparations and substances for medical use; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medical use in in vitro diagnosis; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Ovulation test kits; Pregnancy test kits for home use; Reagent paper for medical or veterinary purposes
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2025
PUBO
PUBLISHED FOR OPPOSITION
02/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/15/2025
DOCK
ASSIGNED TO EXAMINER
01/14/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/14/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2025
NWAP
NEW APPLICATION ENTERED
06/21/2024
Continuous trademark protection
Get notified about every new filing that threatens CLUNGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.